Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary
Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary

Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary

In terms of performance, the stock has delivered a 1-year return of 4.69 per cent and a 3-year return of 45.08 per cent.

DSIJ Intelligence-2 Article rating: 5.0

In terms of performance, the stock has delivered a 1-year return of 4.69 per cent and a 3-year return of 45.08 per cent.

New Diabetes Drug Launched: Affordable Treatment Revolution in India
New Diabetes Drug Launched: Affordable Treatment Revolution in India

New Diabetes Drug Launched: Affordable Treatment Revolution in India

Alkem's commitment to global health improvement is reflected in its diverse product offerings and international presence.

DSIJ Intelligence-1 Article rating: 5.0

Alkem Laboratories Ltd. is a prominent Indian pharmaceutical company known for its high-quality medicines over the past 50 years.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR